(Q64891561)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4722571%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

title

L-dopa level in plasma, primary condition for the kinetic effect (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4722571%20AND%20SRC:MED&resulttype=core&format=json

aromatic amino acid decarboxylase inhibitors

3 October 2019

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4722571

24 February 2023

1 reference

24 February 2023

author name string

W. Birkmayer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4722571

24 February 2023

W. Danielcyk

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4722571

24 February 2023

E. Neumayer

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4722571

24 February 2023

P. Riederer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A4722571

24 February 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4722571

24 February 2023

publication date

1 January 1973

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4722571%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

3 October 2019

http://link.springer.com/content/pdf/10.1007/BF01244666.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF01244666/fulltext.html

24 February 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF01244666

24 February 2023

1 reference

Journal of Neural Transmission

24 February 2023

published in

34

2

133–43

1973

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=4722571

24 February 2023

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4722571%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4722571%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

page(s)

133-143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4722571%20AND%20SRC:MED&resulttype=core&format=json

Treatment of Parkinson's disease with L-DOPA and decarboxylase inhibitor

3 October 2019

cites work

1 reference

12 December 2020

Modification of Parkinsonism--chronic treatment with L-dopa

1 reference

12 December 2020

Biochemical bases for the treatment of Parkinson's syndrome with L-dopa

1 reference

12 December 2020

L-dopa treatment failure: explanation and correction

1 reference

12 December 2020

[Parkinsonism and plasma metabolism of dihydroxyphenylalanine administered with an inhibitor of decarboxylase]

1 reference

12 December 2020

The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia

1 reference

12 December 2020

[Further experimental studies on the catecholamine metabolism in extrapyramidal diseases (Parkinson and chorea syndromes)].

1 reference

12 December 2020

THE DISTRIBUTION OF DOPAMINE AND DOPA IN VARIOUS ANIMALS AND A METHOD FOR THEIR DETERMINATION IN DIVERSE BIOLOGICAL MATERIAL

1 reference

12 December 2020

Action of amantadine HCl alone and in combination with L-dopa on parkinsonism

1 reference

12 December 2020

L-dopa therapy of Parkinson's disease: plasma L-dopa concentration, therapeutic response, and side effects

1 reference

12 December 2020

Oral L-dopa treatment of parkinsonism.

1 reference

12 December 2020

Metabolism of levodopa in patients with Parkinson's disease. Radioactive and fluorometric assays

1 reference

12 December 2020

[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

1 reference

12 December 2020

Drug-Induced Changes of Extracerebral Dopa Metabolism in Man

1 reference

12 December 2020

Catecholamine Metabolism During Oral Administration of Levodopa

1 reference

12 December 2020

Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system

11

1 reference

24 February 2023

16

46

231

M. D. Muenter

1971

1 reference

Treatment of Parkinson's disease with amantadine and levodopa. A one-year study

24 February 2023

17

1 reference

24 February 2023

Identifiers

DOI

10.1007/BF01244666

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:4722571%20AND%20SRC:MED&resulttype=core&format=json

3 October 2019

1 reference